(B) Lecture 13: Antibiotics and Antibiotic Resistance Flashcards

1
Q

Antimicrobial agents

A
  • disinfectants
  • antiseptics
  • antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Disinfectants

A

antimicrobial agents that are applied to INANIMATE OBJECTS (floors, tables, walls)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antiseptics

A

antimicrobial agents that are sufficiently NONTOXIC to be applied to LIVING TISSUES (ex. hand sanitizers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antibiotics

A

antimicrobial agents produced by BACTERIA + FUNGI that are exploited by humans
- delivered topically + internally

Most effective therapeutic against bacterial infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Major problems with antibiotics

A
  1. Low interest from pharmaceutical companies to develop new antibiotics (hard to make money when constantly making new antibiotics due to resistance)
  2. Bacterial resistance to antibiotics always happens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Misuse of antibiotics

A
  • empiric use (blinded use): don’t know specific infection
  • increased use of broad-spectrum agents: kills things you don’t want
  • pediatric use for viral infections
  • patients who don’t complete course (ex. TB)
  • antibiotics in animal feeds
  • global travel = resisted organisms/bacteria spread quickly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Measuring Antibiotic Activity

A

Minimum inhibitory concentration (MIC)
- MIC = point where bacteria can’t grow/ lowest conc of agent that inhibits growth
- series of culture tubes w/ diff conc. of agent + check for growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do antibiotics work?

A

Antibiotics target essential bacterial components:
- cell wall synthesis
- protein synthesis (ex. ribosomes)
- DNA/RNA synthesis
- folate synthesis
- cell membrane alteration

Targets are not present in eukaryotic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Beta Lactam Antibiotics

A

Ex. Penicillin, Methicillin

  • contains a beta lactam ring
  • INHIBITS CELL WALL SYNTHESIS in bacteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Penicillin

A

a beta lactam antibiotic

Beta lactams bind bacterial “penicillin-binding proteins (PBPs)
- PBPs are transpeptidases and make peptide cross-links
- no peptide cross-links = weak cell wall = cell death

BUT some bacteria produce a beta lactamase (enzyme that destroyed ring and antibiotic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Methicillin

A

a beta lactam antibiotic

  • contains a beta lactam ring
  • chemically modified penicillin
  • CAN’T be cleaved by beta lactamases

BUT some bacteria can produce a different ‘penicillin-binding protein’ (PBP2a) encoded by ‘mec’
- PBP2a doesn’t bind methicillin (or other beta lactams)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Vancomycin

A
  • not a great antibiotic
  • a glycopeptide antibiotic
  • inhibits cell wall synthesis in gram POSITIVES
  • often a “last resort” (ex. MRSA)

Binds peptide linkage at terminal D-Ala-D-Ala residues and inhibits transpeptidation
- resistance genes change those to D-Ala-D-Lac and vancomycin can no longer bind

Resistance is encoded by van genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bacterial strategies for antibiotic resistance

A
  • prevention of antibiotic entry (gram NEGATIVE outer membrane + mycobacteria cell envelope)
  • antibiotic modification (beta lactamase)
  • efflux of antibiotic (actively pump out the antibiotic)
  • alteration of antibiotic target (PBPs, ribosome modifications)
  • bypassing antibiotic action (use environmental folic acid)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Antibiotic resistance genes

A
  • many mechanisms of antibiotic resistance are GENETICALLY ENCODED (ex. mec, beta lactamase, efflux pumps)
  • can produce HIGH levels of antibiotic resistance
  • often encoded on MOBILE genetic elements (ex. plasmids, transposons) that allow for horizontal gene transfer = SUPERBUGS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Superbugs

A

bacteria that are resistant to MULTIPLE antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Horizontal gene transfer

A

new genes are acquired from another source

  1. bacterial transformation: donor cell releases DNA and recipient picks it up
  2. bacterial transduction: phage infects bacteria and phage-infected donor cell releases phage to infect a recipient cell
    - can pass on resistance genes
  3. bacterial conjugation: donor cell and recipient cell combine and plasmid moves from donor to recipient
17
Q

Klebsiella pneumoniae

A

Gram NEGATIVE

  • important cause of nosocomial pneumonia
  • produces a capsule
  • commonly resistant to multiple antibiotics
  • first documented source of NDM-1 (a carbapenemase)
  • carbapenem antibiotics are beta-lactamase resistant beta-lactams w/ broad spectrum activity
18
Q

Nosocomial

A

a disease acquired in a HEALTHCARE setting

19
Q

NDM-1

A

a carbapenemase

  • carbapenem antibiotics are beta-lactamase resistant beta-lactams w/ broad spectrum activity

Now widespread in other Gram NEGs = CRE (carbapenem-resistant Enterobacteriaceae)

20
Q

Clostridia

A
  • gram-POSITIVE, rod shaped
  • endospore-formers
  • strict ANAEROBES, vegetative cells killed by O2
  • generally found in SOIL + INTESTINAL TRACTS of animals
  • can cause life-threatening diseases mediated by EXOTOXINS

Examples
- C. difficile: pseudomembranous colitis
- C. tetani: tetanus
- C. botulinum: botulism
- C. perfringens: food-borne illness

21
Q

C. diff

A

Clostridoides difficile

Can exist as
- asymptomatic carrier in large intestine
- cause of mild to moderate diarrhea
- cause of life-threatening pseudomembranous colitis (antibiotic-associated diarrhea)

NOSOCOMIAL environments (in nursing homes + hospital environments)

ENDOSPORES can be hard to get rid of

Mode of transmission: FECAL-ORAL ROUTE

22
Q

Pseudomembranous colitis

A
  • inflammatory condition of LARGE intestine
  • most important risk factor: having recently received an antimicrobial agent
  • antibiotics suppress normal microbiota = persistence of C. diff endospores
  • when antibiotic is stopped, spores germinate; overgrowth of C. diff = toxins
  • C. diff is not invasive but EXOTOXINS cause damage + inflammation to intestinal lining of large intestine
  • diarrhea, ab pain, fever, nausea
23
Q

How does C. diff work?

A

C. diff produces A-B toxins called the LARGE CLOSTRIDIAL CYTOTOXINS

“A-B” designates two domains
- A-domain: the ACTIVE portion of the toxin that carries the enzymatic activity
- B-domain: the portion of toxin responsible for BINDING + uptake by host cell

24
Q

A-domain

A

the ACTIVE portion of the toxin that carries enzymatic activity

inactivates key regulatory proteins of host cells = dysregulation of cell processes like inflammation, cytoskeletal rearrnagements and cell death

25
Q

Diagnosis and Treatment of C. diff

A

Diagnosis
- take history (antibiotic use)
- lab tests to confirm C. diff
- endoscopy and toxin detection

Treatment
- discontinue inciting antibiotic
- fluids
- antibiotics more specific for C. diff - oral vancomycin or I.V. metronidazole
- AVOID ANTIDIARRHEAL AGENTS - would cause decreased toxin clearance

26
Q

Fecal microbiota transplantation

A

Take feces from a healthy person and transplants that into large intestine of infected person

Fixes microbiota

27
Q

Study: Duodenal Infusion of Donor feces for Recurrent C. diff

Fecal microbiota transplantation

A

Methods
- 3 therapies randomly assigned: vancomycin + bowel lavage + donor feces infusion; standard vancomycin; vancomycin + bowel lavage
- goal: resolution of diarrhea w/ C. diff w/o relapse after 10 weeks

Results
- study stopped after interim analysis
- patients who got donor-feces infusion, showed increased fecal bacteria diversity, similar to healthy ppl